Making Cervical Cancer Screening More Accessible: The Promise of HPV Self-Sampling in Canada

An advocacy piece written by Women in Global Health Canada. WGH Canada is committed to advocacy to eliminate cervical cancer in Canada on this day and to joining forces with other advocacy organizations and leaders.
Human papillomavirus (HPV) is a common viral infection that can affect the skin and mucous membranes, sometimes causing growths known as warts. There are over 200 types of HPV, some of which are associated with genital warts, while others are linked to the development of certain cancers, including cervical cancer. Although most HPV infections resolve on their own without causing serious complications, persistent infection with high-risk HPV types can lead to abnormal cellular changes that may eventually develop into cervical cancer. HPV is primarily transmitted through sexual contact and intimate skin-to-skin contact. Vaccines are available to protect against the HPV types most commonly associated with genital warts and HPV-related cancers.
Cervical cancer screening plays an important role in the early detection and prevention of cervical cancer. Traditionally, screening has involved a Pap test, in which a healthcare provider collects cells from the cervix to identify abnormal cellular changes that may progress to cancer. HPV testing, on the other hand, detects the presence of high-risk HPV types associated with cervical cancer. Despite the importance of screening, many individuals may delay or avoid these examinations due to discomfort, anxiety, pain, embarrassment, or the invasive nature of the procedure.
HPV self-collection kits offer a promising approach to addressing these barriers and improving access to cervical cancer screening. These kits allow individuals to collect their own vaginal sample for HPV testing in a private and comfortable setting, at a time and location that is convenient for them. By reducing the need for a clinician-collected sample and providing individuals with greater autonomy over the screening process, HPV self-collection has the potential to improve screening participation, particularly among populations that face barriers to accessing traditional cervical cancer screening services. Ultimately, increasing access to HPV self-collection could contribute to earlier identification of individuals at risk and support broader efforts to prevent cervical cancer.
A relevant Canadian initiative to highlight for Cervical Cancer Elimination Day is Dr. Jennifer Brown Broderick’s HPV Self-Sampling for Primary Cervical Cancer Screening in Underserved Saskatchewan Women. In 2021, Dr. Brown Broderick, a gynecologic oncologist, received a $100,000 Women Leading Philanthropy grant to improve cervical cancer screening among underserved women in Saskatchewan. The project focused on increasing access to HPV self-sampling, allowing women to collect their own samples.
A pilot study led by Dr. Brown-Broderick examined the effectiveness of HPV self-collection kits in improving cervical cancer screening participation among underserved populations in urban and rural Saskatchewan [2]. The study involved 500 individuals who had not undergone cervical cancer screening in the previous four years, with half receiving kits by mail and the other half receiving them directly through healthcare clinics. The findings demonstrated that in-person distribution resulted in nearly twice the screening participation rate compared to mailouts (20.8% versus 11.2%). Additionally, an inner-city clinic in Saskatoon reported both the highest screening participation and HPV positivity rates. These findings highlighted the importance of HPV self-collection to address barriers to cervical cancer screening, particularly among underserved populations, while emphasizing the importance of accessible and targeted distribution strategies.
References
- Royal University Hospital Foundation. (n.d.). Dr. Jennifer Brown Broderick. https://ruhf.org/dr-jennifer-brown-broderick/
- Vink, E., Antaya, G., Hamula, C., Holinaty, C., Minion, J., Pond, G. R., … & Brown Broderick, J. (2024). HPV self-sampling for cervical cancer screening in under-screened Saskatchewan populations: a pilot study. Current Oncology, 31(8), 4261-4269.
Biography

Jennifer Brown Broderick. MD, MSc Eng., FRCSC. DABOG
A practicing engineer, Dr. Brown Broderick later shifted to medicine, graduating from the University of Alberta in 2009. Having completed her residency and fellowship in gynecologic oncology at the University of Ottawa, she practiced for 4 years in Rochester, NY, before returning to Canada in July 2020. She is currently a practicing gynecologic oncologist in Saskatoon and assistant professor of oncology at the University of Saskatchewan. Dr. Brown Broderick currently serves as the primary site investigator for several Phase 3 clinical trials in gynecologic oncology, including Saskatchewan’s first-ever clinical trial in gynecologic oncology. Along with other industry-led clinical trials, Dr. Brown Broderick leads an investigator-initiated project, “Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Underserved Saskatchewan Women.” She has a particular interest in immunotherapy in gynecologic oncology and is the former co-lead of the COP in immunotherapy for the GOC.